United States Securities and Exchange Commission · EDGAR Accession 0001787792-26-000009

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-37002
Issuer CIK 1787792
Raising via DEALMAKER SECURITIES LLC

Fisher Wallace Laboratories, Inc.

CorporationDEIncorporated 2019BROOKLYN, OHfisherwallace.com
Nature of amendmentCorrection to "principal equity holders" chart; addition of compensation information for "directors, executive officers, and significant employees"
A

The Offering

as disclosed in this filing
Common Stock
$11.30
$10,526
$4,398,748
July 31, 2026
47 days remaining
$0max $4,398,748

Target is 0% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Revenue −28% YoYBurn decreasingDebt / assets 888%3 employees
Line itemMost recent FYPrior FYΔ
Revenue34,26147,412▼ 28%
Cost of goods sold5,0493,012▲ 68%
Net income(1,447,538)(1,579,900)▲ burn
Total assets144,634154,382▼ 6%
Cash & equivalents48,14241,626▲ 16%
Accounts receivable00
Short-term debt591,311596,721▼ 1%
Long-term debt693,612925,582▼ 25%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-37002 · all filings under this campaign
Loading campaign history…